Robert Charles Swanton, Director at BICYCLE THERAPEUTICS PLC (BCYC), sold 102 shares at $8.55 ($872) on 2025-10-02, disclosed to the SEC on 2025-10-06.
Scheduled sale ($872) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.